The effectiveness of inhaled zanamivir and oral oseltamivir - experience in a regional hospital

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: LAI, Shu-Chen (Tungs’ Taichung MetroHarbor Hospital, Pharmacy Department, Taichung City, China Taiwan)
  • Co-author(s): Shu-Chen Lai: Department of Pharmacy, Tungs’ Taichung MetroHarbor Hospital, Taichung, Taiwan, Province of China;, Taichung City New Pharmacist Association, Taichung, Taiwan, Province of China
    Po-I Chen: Department of Pharmacy, Tungs’ Taichung MetroHarbor Hospital, Taichung, Taiwan, Province of China;, Taichung City New Pharmacist Association, Taichung, Taiwan, Province of China
    Pei-Liang Chen: Department of Pharmacy, Tungs’ Taichung MetroHarbor Hospital, Taichung, Taiwan, Province of China;, Taichung City New Pharmacist Association, Taichung, Taiwan, Province of China
  • Abstract:

    Background

    The World Health Organization (WHO) had previously encouraged member states to stockpile and gain experience of using neuraminidase inhibitors (NIs). We compared the clinical effectiveness of zanamivir and oseltamivir in patients with influenza.

    Purpose

    Analyzed the effectiveness of NIs comprise inhaled zanamivir and oral oseltamivir on..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login